As most women get older, and especially after menopause, the milk-producing glands (lobules) shut down -- a process known as lobular regression, or involution. Since breast cancer is thought to originate in the lobules, their reduced size and number decreases the chance of cancer formation. Women who experience complete involution have half the risk of developing breast cancer of those who do not.
"The risk of breast cancer increases among women who have no breast involution as they age," says Lynn Hartmann, M.D., Mayo Clinic oncologist and lead investigator of the study. "This study identifies specific groups of women who are at lower or higher risks of breast cancer due to their extent of involution and factors such as age, family cancer history, reproductive history and types of benign breast disease."Breast cancer is a significant threat to women. The American Cancer Society reports that more than 250,000 women will be diagnosed in the United States this year with breast cancer, and at least 40,000 will die from it. Dr. Hartmann's team is working to better understand the steps that precede breast cancer and which of them can be recognized in benign breast tissue. In a previous study, published in the New England Journal of Medicine (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16034008&query_
hl=3&itool=pubmed_docsum) in 2005, they showed that certain types of benign breast disease increase the risk of breast cancer.
The current study contributes to Mayo's emerging model that seeks to define individual women's risk more precisely and thus be able to tailor screening and risk-reducing measures to women depending on their individual risks.
The investigators found that among women with benign breast disease and little or no breast tissue involution, risk for developing breast cancer was twice that of women whose breast glandular tissues had been replaced completely with connective and fatty tissue (53 percent had complete involution as they aged beyond 70 years).
The study included 8,736 women who had breast biopsies at Mayo Clinic that were benign during a 25-year period starting in 1967. Breast tissue samples from this Mayo Clinic Benign Breast Disease cohort were evaluated to determine extent of involution. As a group, the Mayo cohort was at 40 percent increased risk of breast cancer compared to a larger population of presumably healthy women who comprise the Iowa Surveillance, Epidemiology and End Results (SEER) registry. This increased risk has been seen in other cohorts of women with benign breast tissue. However, those in the Mayo cohort who had complete breast lobular involution had no more risk of developing breast cancer than the baseline established in the Iowa SEER cohort.
The researchers found that hormone replacement therapy and prior pregnancies play a role in progression of involution. Hormonal replacement therapy had a slight impact on amount of involution. More women (22.9 percent) who never took hormone replacement had complete involution of mammary tissue than women (20.3 percent) who were treated with estrogen, progesterone or combinations of these two female hormones. Women who gave birth to more than three children retained a greater number of breast lobules. More women (27 percent) who had no children had complete involution, while only 18 percent of women with four children completed mammary involution. Breast-feeding of children had no impact on extent of involution.
"The research community has not focused on breast involution in recent years, nor has this natural process previously been linked to breast cancer risk," reports Dr. Hartmann. "Our study is the first to establish that the extent of breast involution relates directly to risk for breast cancer." She also says that women who would otherwise be considered at high risk (such as those with atypia) appear to have reduced risk when greater degrees of involution are present.
By documenting involution status in a woman's background breast tissue, cancer physicians have another important variable to aid in predicting a woman's risk, at least in women with benign breast tissue. This information can be considered with epidemiological background, individual factors such as age and reproductive history. Ultimately, it is hoped that biomarkers will be defined that contribute to the risk of breast cancer, and these will be integrated into a comprehensive Mayo model for breast cancer risk assessment.
Dr. Hartmann added that by appraising an individual's personal information within a complete, integrated model for predicting risk, every woman's breast cancer risk can be determined with precision and accuracy, leading to the patient's optimal peace of mind based on accurate risk assessment and the appropriate level of preventive intercession and awareness.
Diagnoses: When Are Several Opinions Better Than One?
19.07.2016 | Max-Planck-Institut für Bildungsforschung
High in calories and low in nutrients when adolescents share pictures of food online
07.04.2016 | University of Gothenburg
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences